Generic Name and Formulations:
Meclizine HCl 12.5mg, 25mg; tabs.
Various generic manufacturers
Indications for Meclizine:
Motion sickness prophylaxis. Vertigo of vestibular origin.
Motion sickness: 25–50mg 1 hour prior to departure, repeated every 24 hours as needed. Vertigo: 25–100mg/day in divided doses.
Asthma. Glaucoma. GI or GU obstruction. Hepatic or renal impairment. Elderly. Pregnancy (Cat.B). Nursing mothers.
Alcohol, tranquilizers, sedative-hypnotics potentiate CNS depression. May be potentiated by CYP2D6 inhibitors.
Drowsiness, sedation, dry mouth, blurred vision.
Formerly known under the brand name Antivert.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Managing Immune-Related Adverse Events
- PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC